Search

Author/Creator Wolbink, G

1. A prospective, randomised, placebo-controlled study to identify biomarkers associated with active treatment in psoriatic arthritis: effects of adalimumab treatment on synovial tissue. Issue 8 (22nd July 2008)

Authors:
van Kuijk, A W R; Gerlag, D M; Vos, K; Wolbink, G; de Groot, M; de Rie, M A; Zwinderman, A H; Dijkmans, B A C; Tak, P P
Journal:
Annals of the rheumatic diseases
Issue:
Volume 68:Issue 8(2009)
Page Start:
1303
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

2. A1.45 Hyperglycosylation of ACPA-IGG variable domains modulates reactivity to citrullinated antigens. (31st January 2014)

Authors:
Rombouts, Y; Willemze, A; van Beers, J J B C; Shi, J; Kerkman, P F; Janssen, G M C; van Veelen, P A; Zaldumbide, A; Hoeben, R C; Pruijn, G J; Deelder, A M; Wolbink, G; Rispens, T; García-Vallejo, J J; van Kooyk, Y; Huizinga, T W J; Wuhrer, M; Trouw, L A; Scherer, H U; Toes, R E M
Journal:
Annals of the rheumatic diseases
Issue:
Volume 73:Supplement 1(2014)
Page Start:
A19
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

3. A7.14 Effect of prednisone on type I interferon signature in rheumatoid arthritis: consequences for response prediction to rituximab. (13th February 2015)

Authors:
de Jong, TD; Vosslamber, S; Blits, M; Wolbink, G; Nurmohamed, MT; van der Laken, CJ; Jansen, G; Mantel, E; Lübbers, J; de Ridder, S; Voskuyl, AE; Verweij, CL
Journal:
Annals of the rheumatic diseases
Issue:
Volume 74(2015)Supplement 1
Page Start:
A80
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

6. DOP27 Humoral immune response after SARS-CoV-2 vaccination in patients with immune-mediated inflammatory diseases treated with immunosuppressive therapy - a Target to B! study. (21st January 2022)

Authors:
Volkers, A; Wieske, L; van Dam, K; Steenhuis, M; Stalman, E; Kummer, L; van Kempen, Z; Killestein, J; Tas, S; Boekel, L; Wolbink, G; Takkenberg, B; Spuls, P; Bosma, A; Rutgers, B; Verschuuren, J; van Ouwerkerk, L; van der Woude, D; van Paassen, P; Busch, M
Journal:
Journal of Crohn's and colitis
Issue:
Volume 16(2022)Supplement 1
Page Start:
i079
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

8. Imaging and serum analysis of immune complex formation of radiolabelled infliximab and anti-infliximab in responders and non-responders to therapy for rheumatoid arthritis. Issue 2 (22nd June 2006)

Authors:
van der Laken, C J; Voskuyl, A E; Roos, J C; Stigter van Walsum, M; de Groot, E R; Wolbink, G; Dijkmans, B A C; Aarden, L A
Journal:
Annals of the rheumatic diseases
Issue:
Volume 66:Issue 2(2007)
Page Start:
253
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

9. Personalised treatment using serum drug levels of adalimumab in patients with rheumatoid arthritis: an evaluation of costs and effects. Issue 2 (21st November 2013)

Authors:
Krieckaert, C L M; Nair, S C; Nurmohamed, M T; van Dongen, C J J; Lems, W F; Lafeber, F P J G; Bijlsma, J W J; Koffijberg, H; Wolbink, G; Welsing, P M J
Journal:
Annals of the rheumatic diseases
Issue:
Volume 74:Issue 2(2015)
Page Start:
361
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗